170 related articles for article (PubMed ID: 21369941)
1. Prognostic impact of S100A9 overexpression in non-small cell lung cancer.
Kawai H; Minamiya Y; Takahashi N
Tumour Biol; 2011 Aug; 32(4):641-6. PubMed ID: 21369941
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
3. Relation between prognosis and expression of metastasis-associated protein 1 in stage I non-small cell lung cancer.
Yu Y; Wang Z; Zhang MY; Liu XY; Zhang H
Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):166-9. PubMed ID: 20935042
[TBL] [Abstract][Full Text] [Related]
4. LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.
Liu Y; Xing Y; Wang H; Yan S; Wang X; Cai L
Thorac Cancer; 2018 Dec; 9(12):1725-1732. PubMed ID: 30273983
[TBL] [Abstract][Full Text] [Related]
5. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer.
Qiu ZX; Wang L; Han J; Liu D; Huang W; Altaf K; Qiu XS; Javed MA; Zheng J; Chen BJ; Li WM
Cancer Sci; 2012 Oct; 103(10):1774-9. PubMed ID: 22738312
[TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer.
Lafuente-Sanchis A; Zúñiga Á; Galbis JM; Cremades A; Estors M; Martínez-Hernández NJ; Carretero J
Clin Transl Oncol; 2016 Aug; 18(8):798-804. PubMed ID: 26542178
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of S100A9 expression in patients with clear cell renal cell carcinoma.
Koh HM; An HJ; Ko GH; Lee JH; Lee JS; Kim DC; Song DH
Medicine (Baltimore); 2019 Oct; 98(40):e17188. PubMed ID: 31577709
[TBL] [Abstract][Full Text] [Related]
11. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
[TBL] [Abstract][Full Text] [Related]
12. MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer.
Wang YZ; Wu KP; Wu AB; Yang ZC; Li JM; Mo YL; Xu M; Wu B; Yang ZX
Tumour Biol; 2014 Oct; 35(10):9815-21. PubMed ID: 24986569
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
14. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
[TBL] [Abstract][Full Text] [Related]
16. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
[TBL] [Abstract][Full Text] [Related]
17. Activating enhancer-binding protein-2β nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection.
Kim MP; Chen Y; Bekele BN; Lopez A; Khanna A; Chen JQ; Spitz MR; Behrens C; Solis L; Wismach M; Ji L; Wistuba II; Roth JA; Katz RL
Ann Thorac Surg; 2011 Sep; 92(3):1044-50. PubMed ID: 21871297
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of calcium-binding protein S100A8 and S100A9 expression in non-small cell lung cancer.
Huang H; Huang Q; Tang T; Gu L; Du J; Li Z; Lu X; Zhou X
Thorac Cancer; 2018 Jul; 9(7):800-804. PubMed ID: 29733516
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment
Satoh Y; Motosugi U; Saito A; Omiya Y; Onishi H
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794934. PubMed ID: 30222060
[TBL] [Abstract][Full Text] [Related]
20. FER overexpression is associated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancer.
Kawakami M; Morita S; Sunohara M; Amano Y; Ishikawa R; Watanabe K; Hamano E; Ohishi N; Nakajima J; Yatomi Y; Nagase T; Fukayama M; Takai D
Int J Clin Exp Pathol; 2013; 6(4):598-612. PubMed ID: 23573306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]